bioAffinity Technologies (BIAF) Competitors $0.28 -0.01 (-4.83%) Closing price 07/3/2025 03:55 PM EasternExtended Trading$0.28 +0.00 (+0.36%) As of 07/3/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIAF vs. LUNA, FPAY, SGRP, TCJH, DTST, OFAL, SCOR, JOB, GFAI, and LTRPAShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include Luna Innovations (LUNA), FlexShopper (FPAY), SPAR Group (SGRP), Top KingWin (TCJH), Data Storage (DTST), OFA Group (OFAL), comScore (SCOR), GEE Group (JOB), Guardforce AI (GFAI), and Liberty TripAdvisor (LTRPA). These companies are all part of the "business services" industry. bioAffinity Technologies vs. Its Competitors Luna Innovations FlexShopper SPAR Group Top KingWin Data Storage OFA Group comScore GEE Group Guardforce AI Liberty TripAdvisor Luna Innovations (NASDAQ:LUNA) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment. Do analysts rate LUNA or BIAF? bioAffinity Technologies has a consensus target price of $6.00, indicating a potential upside of 2,073.91%. Given bioAffinity Technologies' stronger consensus rating and higher probable upside, analysts clearly believe bioAffinity Technologies is more favorable than Luna Innovations.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Luna Innovations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to LUNA or BIAF? In the previous week, Luna Innovations had 13 more articles in the media than bioAffinity Technologies. MarketBeat recorded 14 mentions for Luna Innovations and 1 mentions for bioAffinity Technologies. Luna Innovations' average media sentiment score of 0.43 beat bioAffinity Technologies' score of -1.32 indicating that Luna Innovations is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Luna Innovations 3 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral bioAffinity Technologies 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative Which has more volatility & risk, LUNA or BIAF? Luna Innovations has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of 2.52, meaning that its share price is 152% more volatile than the S&P 500. Do institutionals & insiders believe in LUNA or BIAF? 87.5% of Luna Innovations shares are held by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are held by institutional investors. 7.6% of Luna Innovations shares are held by insiders. Comparatively, 16.9% of bioAffinity Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable earnings and valuation, LUNA or BIAF? Luna Innovations has higher revenue and earnings than bioAffinity Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLuna Innovations$116.61M0.28$9.28MN/AN/AbioAffinity Technologies$8.81M0.89-$9.04M-$0.72-0.38 Is LUNA or BIAF more profitable? Luna Innovations has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -110.53%. Luna Innovations' return on equity of 0.00% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Luna InnovationsN/A N/A N/A bioAffinity Technologies -110.53%-367.64%-154.15% SummaryLuna Innovations beats bioAffinity Technologies on 8 of the 13 factors compared between the two stocks. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.86M$2.88B$5.50B$9.01BDividend YieldN/A2.43%5.38%4.04%P/E Ratio-0.3821.5627.6020.30Price / Sales0.89172.94369.38103.94Price / CashN/A41.9536.6357.47Price / Book1.627.518.055.68Net Income-$9.04M-$55.05M$3.18B$249.13M7 Day Performance-6.76%4.61%2.82%3.30%1 Month Performance-8.91%4.89%3.70%5.20%1 Year Performance-87.28%5.84%35.41%21.38% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies1.9294 of 5 stars$0.28-4.8%$6.00+2,073.9%-87.3%$7.86M$8.81M-0.3810Negative NewsLUNALuna Innovations0.2837 of 5 stars$0.75flatN/A-69.1%$25.47M$116.61M0.00390News CoverageGap DownFPAYFlexShopper3.121 of 5 stars$1.24+5.1%$3.25+162.1%-6.9%$25.33M$139.80M-5.39140SGRPSPAR Group3.775 of 5 stars$1.04-1.0%N/A-57.0%$24.62M$196.81M2.043,425Gap DownTCJHTop KingWinN/A$1.65+6.8%N/A+931.8%$24.34M$3.99M0.00145DTSTData Storage0.3495 of 5 stars$3.36+0.3%N/A-47.0%$23.92M$25.37M168.0860OFALOFA GroupN/A$1.60-8.6%N/AN/A$23.38MN/A0.006Quiet Period ExpirationSCORcomScore3.169 of 5 stars$4.84+3.9%$10.75+122.1%-61.7%$23.06M$354.96M-0.301,200Gap DownJOBGEE Group0.5723 of 5 stars$0.20-2.0%N/A-36.9%$21.98M$111.28M-0.91310Gap UpGFAIGuardforce AI3.103 of 5 stars$1.13-2.6%$4.50+298.2%-46.4%$20.66M$36.35M0.001,547LTRPALiberty TripAdvisorN/A$0.26flatN/AN/A$20.29M$1.68B-0.113,100 Related Companies and Tools Related Companies Luna Innovations Competitors FlexShopper Competitors SPAR Group Competitors Top KingWin Competitors Data Storage Competitors OFA Group Competitors comScore Competitors GEE Group Competitors Guardforce AI Competitors Liberty TripAdvisor Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIAF) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
